Amyloid fibril formation and protein misassembly: a structural quest for insights into amyloid and prion diseases (Q41509791)

1 October 2017

1 reference

title

Amyloid fibril formation and protein misassembly: a structural quest for insights into amyloid and prion diseases (English)

1 reference

1 October 2017

0 references

Kelly JW

1

1 reference

1 October 2017

1 May 1997

1 reference

1 October 2017

1 reference

1 October 2017

5

1 reference

1 October 2017

595-600

1 reference

1 October 2017

5

1 reference

In pursuit of the molecular structure of amyloid plaque: new technology provides unexpected and critical information

1 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous β-sheet helix

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Domain swapping: entangling alliances between proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

3D domain swapping: a mechanism for oligomer assembly

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Alternative conformations of amyloidogenic proteins govern their behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

A chemical approach to elucidate tin mechanism of transthyretin and β-protein amyloid fibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

For protein misassembly, it's the "I" decade

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Defective protein folding as a basis of human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

A role for destabilizing amino acid replacements in light-chain amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

The chemistry of scrapie infection: implications of the 'ice 9' metaphor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Non-genetic propagation of strain-specific properties of scrapie prion protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Conformational transitions in peptides containing two putative alpha-helices of the prion protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Support for the prion hypothesis for inheritance of a phenotypic trait in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Mutations and off-pathway aggregation of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

1 reference

7 January 2021

Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Normal transthyretin and synthetic transthyretin fragments form amyloid-like fibrils in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Solvent effects on self-assembly of beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Observation of metastable Abeta amyloid protofibrils by atomic force microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

The nanometer-scale structure of amyloid-beta visualized by atomic force microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Treatment of amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

1 reference

7 January 2021

Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Fibril in senile systemic amyloidosis is derived from normal transthyretin

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin).

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Transthyretin mutations in health and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Structural and genetic analysis of protein stability

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Strjcture of human plasma prealbumin at 2-5 A resolution. A preliminary report on the polypeptide chain conformation, quaternary structure and thyroxine binding

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Structure of Met30 variant of transthyretin and its amyloidogenic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Alteration in molecular structure which results in disease: the Met-30 variant of human plasma transthyretin

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Structure of the Val122Ile variant transthyretin - a cardiomyopathic mutant.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

To fold or not to fold....

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Structure and dynamics of the acid-denatured molten globule state of alpha-lactalbumin: a two-dimensional NMR study

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

NMR determination of residual structure in a urea-denatured protein, the 434-repressor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Structural characterization of monellin in the alcohol-denatured state by NMR: evidence for beta-sheet to alpha-helix conversion

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Examination of the Structure of the Transthyretin Amyloid Fibril by Image Reconstruction from Electron Micrographs

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

NMR structure of the mouse prion protein domain PrP(121-231)

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Structural model for the beta-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: analysis by x-ray diffraction.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Inhibiting transthyretin amyloid fibril formation via protein stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

Computer graphics in drug design: molecular modeling of thyroid hormone-prealbumin interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900215-3

7 January 2021

10.1016/S0969-2126(97)00215-3

Identifiers

DOI

1 reference

1 October 2017

1 reference

PubMed ID

9195890